The epithelial proliferation accompanied by SLC5A2 upregulation, rather than cellular hypertrophy, has been found to predominantly occur in the hypertrophic kidney in both T1D and T2D (Berra et al., 2020; Lai et al., 2022). Here, SLC5A2 is linked to type 2 diabetes mellitus.